VAXXINITY
Vaxxinity, Inc. is a U.S.-based, clinical stage biotechnology company, that aims to democratize health by bringing the efficiency of vaccines to chronic diseases. Vaxxinity has a proprietary technology platform that has enabled the innovation of synthetic peptide vaccines designed to treat and prevent chronic diseases, including Alzheimer's, Parkinson's, migraine, and hypercholesterolemia, as well as infectious diseases, including COVID-19. Vaxxinity has designed its pipeline to achieve a historic global impact on human health.
VAXXINITY
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2019-01-01
Address:
Dallas, Texas, United States
Country:
United States
Website Url:
http://www.vaxxinity.com
Total Employee:
11+
Status:
Active
Total Funding:
9.25 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Analytics Global Site Tag Mobile Non Scaleable Content IPv6
Similar Organizations
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Coalition for Epidemic Preparedness Innovations
Coalition for Epidemic Preparedness Innovations investment in Grant - Vaxxinity
White Buffalo Capital
White Buffalo Capital investment in Seed Round - Vaxxinity
Key Employee Changes
Official Site Inspections
http://www.vaxxinity.com Semrush global rank: 6.09 M Semrush visits lastest month: 1.13 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Vaxxinity"
Vaxxinity - Crunchbase Company Profile & Funding
Vaxxinity is a biotechnology company that enables the innovation of synthetic peptide vaccines to prevent or treat infectious diseases. View contacts for Vaxxinity to access new leads and …See details»
Vaxxinity - LinkedIn
Our mission is to democratize health by pioneering the third biologic revolution | Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health.See details»
Vaxxinity Company Profile 2024: Stock Performance & Earnings
Vaxxinity Inc is a biotechnology company committed to democratizing healthcare across the globe. The company is pioneeri. One of Vaxxinity’s 6 competitors is Merck & Co., a …See details»
A Potential Parkinson’s Treatment Has Promising Results
Jun 20, 2024 · The Florida-based biotech company Vaxxinity developed a vaccine, or what it calls an active immune medicine, to train the immune system to attack only abnormal versions of …See details»
Vaxxinity, Inc. (VAXX) Latest Stock News & Headlines - Yahoo …
Get the latest Vaxxinity, Inc. (VAXX) stock news and headlines to help you in your trading and investing decisions.See details»
Mei Mei Hu | World Economic Forum
Mei Mei is the CEO of Vaxxinity and a member of the executive committee of United Biomedical, Inc. She oversaw the launch of one of the first endobody vaccines in the world and the successful spin-out of three companies.See details»
Vaxxinity hopes its Covid jab technology will help treat …
Jun 13, 2021 · US biotech company Vaxxinity has raised the prospect of breakthroughs in treating Alzheimer’s and Parkinson’s as a result of the unprecedented resources and energy channelled into vaccine...See details»
Vaxxinity, Inc. (VAXX) - Yahoo Finance
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States.See details»
Vaxxinity CEO Mei-Mei Hu: Advancing Vaccine …
May 19, 2021 · Mei Mei Hu has taken an unconventional path to biotech’s upper echelons. She is the co-founder and CEO of Vaxxinity (formerly known as COVAXX), a biotech company that is determined to democratise health. Over …See details»
Vaxxinity, Inc. Company Profile | Merritt Island, FL | Competitors ...
Vaxxinity, Inc. Company Profile | Merritt Island, FL | Competitors, Financials & Contacts - Dun & BradstreetSee details»
Vaxxinity, Inc. (VAXX) Stock Price, News, Quote & History - Yahoo …
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States.See details»
Vaxxinity (OTCPK:VAXX) - Stock Price, News & Analysis - Simply …
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States.See details»
Vaxxinity Receives FDA Fast Track Designation for UB-311 for
DALLAS, May 02, 2022 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX ), a company pioneering the development of a new class of immunotherapeutic vaccines, today announced …See details»
VAXX Stock Price Quote | Morningstar
Nov 18, 2024 · See the latest Vaxxinity Inc Class A stock price (VAXX:PINX), related news, valuation, dividends and more to help you make your investing decisions.See details»
Vaxxinity: supplanting mAbs with vaccines for chronic disease
Nov 7, 2020 · Vaxxinity aims to disrupt the biologics market with a vaccine platform that replaces mAbs for chronic disease by inducing patients’ immune systems to manufacture therapeutic …See details»
UB-311 - Wikipedia
UB-311 is a vaccine targeting β-amyloid and hence anti-amyloid agent which is under development for the treatment of Alzheimer's disease. [2][3] It is under development by …See details»
UB-612 - Wikipedia
UB-612 is a COVID-19 vaccine candidate developed by United Biomedical Asia [zh], and Vaxxinity, Inc. [2] It is a peptide vaccine. [3][4] It is composed of SARS-CoV-2 S1-RBD protein …See details»
Vaxxinity doses first subject in Phase III Covid-19 booster vaccine …
Mar 29, 2022 · Vaxxinity has commenced dosing of subjects in a Phase III pivotal clinical trial of its next-generation Covid-19 booster vaccine candidate, UB-612. The trial has enrolled and …See details»
Why Vaxxinity Stock Is Not a Buy After the IPO - Money Morning
Nov 8, 2021 · Founded in 2014, Vaxxinity's wants to disrupt how patients diagnosed with chronic diseases are currently being treated. Using its synthetic peptide vaccine platform - or the …See details»
Current peptide vaccine and immunotherapy ... - Wiley Online …
Jun 24, 2022 · Peptide vaccines and immunotherapies against aggregating proteins involved in the pathogenesis and progression of Alzheimer's disease (AD)—the β-amyloid peptide (Aβ) …See details»